A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
2021 · Kidney International · 369 citations
https://doi.org/10.1016/j.kint.2021.03.033
N
Niels Jongs
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
126
Papers
3.4K
Citations
28
h-index
46
i10-index
Niels Jongs is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Diabetes Treatment and Management & Chronic Kidney Disease and Diabetes & Pancreatic function and diabetes. The author has an h-index of 28, co-authored 108 publications.
ORCID: 0000-0002-0882-3656Papers by this author
worksSemaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
2024 · Nature Medicine · 82 citations
https://doi.org/10.1038/s41591-024-03327-6
Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement
2024 · Intensive Care Medicine · 27 citations
https://doi.org/10.1007/s00134-024-07560-y
Effect of disease related biases on the subjective assessment of social functioning in Alzheimer's disease and schizophrenia patients
2020 · Journal of Psychiatric Research · 25 citations
https://doi.org/10.1016/j.jpsychires.2020.11.013
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials
2023 · Kidney International · 17 citations
https://doi.org/10.1016/j.kint.2023.03.037
Clinical trial designs to assess treatment effects on glomerular filtration rate decline
2024 · Kidney International · 9 citations
https://doi.org/10.1016/j.kint.2024.06.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat